Trinity Biotech (TRIB) Non Operating Interest Expenses (2009 - 2010)
Trinity Biotech (TRIB) posted Non Operating Interest Expenses of -$231000.0 for Q1 2010, up 10.81% sequentially from -$259000.0 in Q4 2009, and up 19.79% YoY from -$192834.8 in Q1 2009.
Trinity Biotech (TRIB) Non Operating Interest Expenses (2009 - 2010) Analysis & Trends
Trinity Biotech has reported Non Operating Interest Expenses for 2 years, with the latest figure at -$231000.0 in Q1 2010.
- Quarterly Non Operating Interest Expenses rose 19.79% year-over-year to -$231000.0 in Q1 2010, while the trailing twelve-month figure through Mar 2010 was -$1.1 million (up 34.36% YoY) and the FY2013 annual result came in at $1.2 million, down 44.11% from the prior year.
- Non Operating Interest Expenses improved to -$231000.0 in Q1 2010 per TRIB's latest filing, from -$259000.0 in the prior quarter.
- Over five years, Non Operating Interest Expenses peaked at -$231000.0 in Q1 2010 and troughed at -$348000.0 in Q2 2009.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Operating Interest Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.44 Bn | 193.84 Bn | 7.27 Bn | 351.00 Mn |
| 2 | Stryker | 127.32 Bn | 123.85 Bn | 4.50 Bn | 141.00 Mn |
| 3 | Medtronic | 118.87 Bn | 109.65 Bn | 6.41 Bn | 176.00 Mn |
| 4 | Boston Scientific | 73.47 Bn | 72.93 Bn | 3.85 Bn | 96.00 Mn |
| 5 | Edwards Lifesciences | 51.90 Bn | 47.65 Bn | 1.35 Bn | - |
| 6 | Dexcom | 34.30 Bn | 32.36 Bn | 830.00 Mn | - |
| 7 | GE HealthCare Technologies | 33.74 Bn | 31.63 Bn | 2.18 Bn | 114.00 Mn |
| 8 | Koninklijke Philips | 26.35 Bn | 23.03 Bn | 4.55 Bn | -110.42 Mn |
| 9 | Steris | 23.05 Bn | 22.56 Bn | 684.20 Mn | 15.80 Mn |
| 10 | Trinity Biotech | 6.46 Mn | 1.32 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2010 | -231,000.00 |
| Dec 31, 2009 | -259,000.00 |
| Sep 30, 2009 | -289,000.00 |
| Jun 30, 2009 | -348,000.00 |
| Mar 31, 2009 | -288,000.00 |